科创板上市公司独立董事候选人声明与承诺 本人熊守春，已充分了解并同意由提名人江苏汉邦科技股份有限公司董事会 提名为江苏汉邦科技股份有限公司第二届董事会独立董事候选人。本人公开声明， 本人具备独立董事任职资格，保证不存在任何影响本人担任江苏汉邦科技股份有 限公司独立董事独立性的关系，具体声明并承诺如下： 一、本人具备上市公司运作的基本知识，熟悉相关法律、行政法规、部门规 章及其他规范性文件，具有五年以上法律、经济会计、财务、管理等履行独立董 事职责所必需的工作经验。 二、本人任职资格符合下列法律、行政法规和部门规章以及公司规章的要求： （六）中共中央纪委、教育部、监察部《关于加强高等学校反腐倡廉建设的 意见》的相关规定（如适用）； （七）中国人民银行《股份制商业银行独立董事和外部监事制度指引》等的 相关规定（如适用）； （八）中国证监会《证券基金经营机构董事、监事、高级管理人员及从业人 员监督管理办法》等的相关规定（如适用）； （一）《中华人民共和国公司法》等关于董事任职资格的规定； （二）《中华人民共和国公务员法》关于公务员兼任职务的规定（如适用）； （三）中国证监会《上市公司独立董事管理办法》和上海证券交易 ...

证券代码：688755 证券简称：汉邦科技 公告编号：2025-025 江苏汉邦科技股份有限公司 关于召开 2025 年半年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 会议召开时间：2025 年 09 月 23 日（星期二）15:00-16:00 会 议 召 开 地 点 ： 上 海 证 券 交 易 所 上 证 路 演 中 心 （ 网 址 ： https://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 （一）会议召开时间：2025 年 09 月 23 日（星期二）15:00-16:00 （二）会议召开地点：上证路演中心 （三）会议召开方式：上证路演中心网络互动 三、参加人员 董事长、总经理：张大兵先生 董事会秘书：汤业峰先生 财务总监：顾彬先生 独立董事：钱运华先生、熊守春先生、陈晨先生 投资者可于 2025 年 09 月 16 日（星期二）至 09 月 22 日（星期一）16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 IR ...

汉邦科技公告，2025年上半年营业收入3.49亿元，同比增长5.99%。净利润2779.76万元，同比下降 26.24%。 ...

Group 1 - As of August 19, 2025, Hanbang Technology's stock price closed at 50.74 yuan, down 0.71 yuan or 1.38% from the previous trading day [1] - The trading volume on that day was 19,796 hands, with a transaction amount of 1.01 billion yuan [1] - Hanbang Technology is primarily engaged in the research, development, production, and sales of specialized equipment, located in Jiangsu Province, and classified as a specialized and innovative enterprise [1] Group 2 - The company's total market capitalization is 4.465 billion yuan, while the circulating market value is 839 million yuan [1] - On August 19, the net outflow of main funds was 8.1828 million yuan, accounting for 0.97% of the circulating market value [1] - Over the past five trading days, the cumulative net outflow of main funds reached 10.5153 million yuan, representing 1.25% of the circulating market value [1]

A股总市值首次突破100万亿元大关，百元股阵营迎来强势扩张。 截至8月18日收盘，A股中的百元股数量，已经激增至134只，较年初的69只近乎翻倍。其中，寒武纪-U（688256.SH） 年内大涨超过40%，19日盘中一度突破千元关口，收盘虽然回落至933元/股，但也成为贵州茅台（600519.SH）之后， 最有希望跻身"千元股俱乐部"的标的。 这些A股"豪门"中，哪些行业的百元股涨势最为突出？现有百元股的估值，相较历史高点处于何种水平？且看第一财 经细细梳理。 百元股数量超较年初翻倍 市场普遍将百元股（股价超过100元的个股）的数量，视为衡量市场热度的重要风向标，这类个股因其高股价特性往 往吸引投资者重点关注。 今年以来，A股百元股阵营呈现明显扩张态势。截至8月18日，百元股数量已从年初的69只激增至134只，几乎翻倍。 这一过程中，百元股数量随市场波动而变化明显。2月末，百元股的数量为90只，4月因市场大跌一度缩减至67只，随 后逐步回升至7月末的130余只，到8月18日已突破134只。 百元股的"前三甲"，分别为贵州茅台、寒武纪-U、同花顺（300033.SZ），股价分别为1428.50元/股、950元/ ...

Core Viewpoint - The number of stocks priced over 100 yuan in A-shares has surged to 134, nearly doubling from 69 at the beginning of the year, indicating a strong market expansion and investor interest in high-priced stocks [2][5]. Group 1: Market Expansion - As of August 18, the number of hundred-yuan stocks has increased significantly, with fluctuations observed throughout the year, peaking at 134 stocks [2][3]. - The top three hundred-yuan stocks are Kweichow Moutai, Cambrian, and Tonghuashun, with prices of 1428.50 yuan, 950 yuan, and 404.9 yuan respectively [2][3]. Group 2: Performance of New Hundred-Yuan Stocks - Among the 134 hundred-yuan stocks, 71 are newly listed stocks that entered the hundred-yuan club this year, with many from the electronics and power equipment sectors [3][5]. - Notable performers include Shenghong Technology, which rose from 41.88 yuan to 231.77 yuan, marking a 450% increase, and Guangshengtang, which increased from 31.25 yuan to 172 yuan, achieving a 450% rise [3][5]. Group 3: Industry Characteristics - The majority of new hundred-yuan stocks are concentrated in technology-driven sectors such as power equipment, electronics, pharmaceuticals, and defense [5][6]. - Stocks like Yingstone Innovation and Haibo Sunchron have shown remarkable growth, with increases of 469.71% and 462.38% respectively [4][5]. Group 4: Valuation Trends - Many hundred-yuan stocks are approaching historical high valuations, with 81 stocks having total market values in the top 90th percentile historically [7][8]. - A significant number of stocks, including Tonghuashun and Guangshengtang, are nearing or have reached their historical maximum market values [8][9]. Group 5: Earnings Performance - Earnings performance among high-priced stocks is polarized, with some companies like Borui Pharmaceutical showing significant declines in revenue and profit, while others like Cambrian and Xinyisheng report explosive growth in earnings [10]. - Cambrian's revenue for Q1 2025 reached 1.111 billion yuan, a 4230.22% increase year-on-year, marking its first quarterly profit since listing [10].

Group 1 - The company has developed a microsphere matrix bonding technology with 53 patents, which can reduce the delivery cycle of chromatography consumables by 80% [2] - The company is in the process of constructing a production base for chromatography consumables, which is expected to utilize this technology upon completion [2] - The company has indicated that the initial research and development of the microsphere matrix bonding technology has been completed, and the industrialization base is in the planning stage [2]

Group 1 - The core viewpoint of the article highlights the significant acceleration of IPO processes in the A-share market, particularly driven by companies from Jiangsu province, which leads the nation in several IPO metrics [1][7] - As of August 13, 2023, Jiangsu has seen 17 new A-share listings, the highest in the country, followed by Guangdong with 13 and Zhejiang with 10 [1] - Jiangsu also leads in the number of approved IPO applications with 16 out of 59, accounting for nearly 30% of the total [1][4] Group 2 - The newly listed companies from Jiangsu show strong market performance, with 5 companies having a market capitalization exceeding 10 billion yuan, and the top company, Tianfulong, valued at 19.584 billion yuan [4] - The first-day stock performance of the 17 newly listed companies was impressive, with 15 companies seeing their stock prices double, and two companies, Dingjia Precision and Tiangong Co., both increasing by over 400% [4] - Jiangsu's IPOs cover a diverse range of industries, including traditional chemicals and electronic technology, with three companies each in basic chemicals, machinery, and power equipment sectors [4] Group 3 - The rapid IPO approval process in Jiangsu is notable, with companies like Hansan Technology receiving approval in just 5 days, significantly faster than the industry average [4][8] - The strong performance of Jiangsu's IPOs is attributed to local government support and an optimized capital market ecosystem, which has been a focus of Jiangsu's provincial policies since 2021 [7][8] - Initiatives such as strategic cooperation agreements between Jiangsu's regulatory bodies and local governments aim to enhance the quality of listed companies and support high-quality economic development [7][8]

Core Insights - Chromatography technology has emerged as the preferred method for separation and purification in the biopharmaceutical field due to its efficient separation capabilities and wide application range [1][5][9] - The demand for chromatography media in China is projected to reach 1.9194 million liters in 2024, an increase of 312,400 liters from 2023, with a market size of 12.886 billion yuan, up by 1.823 billion yuan [9][17] - The global chromatography media market is expected to grow to $7.528 billion in 2024, an increase of $626 million from 2023, with projections of reaching $8.157 billion in 2025 [5][9] Industry Definition and Classification - Chromatography media, also known as "chromatographic packing," is essential for separation processes in liquid chromatography (LC) and gas chromatography (GC) [3] - It can be classified based on matrix materials (e.g., silica gel, polymer, agarose, cellulose) and separation modes (e.g., reversed-phase, ion exchange, hydrophobic interaction) [3] Current Industry Status - The global chromatography media industry is rapidly expanding, driven by increased investment in biopharmaceutical research and the growing market for antibodies, vaccines, and recombinant proteins [5][7] - In China, the chromatography media industry is experiencing significant growth, with a production volume of 1.1033 million liters in 2024, an increase of 207,400 liters from 2023 [7][9] Industry Chain - The chromatography media industry encompasses research, production, sales, and technical services, with high technical barriers involving materials science and bioengineering [11] - The upstream includes raw materials like silica and polymer microspheres, while the downstream applications are primarily in biopharmaceuticals and industrial separation [11] Competitive Landscape - The chromatography media market is dominated by foreign companies such as Cytiva and ThermoFisher, which hold over 50% of the market share in China [13] - Domestic companies like Suzhou Nanwei Technology and Saifen Technology are emerging as key players in the market, focusing on domestic substitution and innovation [13][16] Development Trends - The chromatography media industry is witnessing a trend towards accelerated domestic substitution and performance upgrades, with increasing adoption of domestic products in clinical and commercial projects [23][24] - As biopharmaceutical projects enter commercialization, there is a heightened demand for high-quality separation and purification products, leading to innovations in chromatography media [24][25]

Core Viewpoint - Jiangsu's IPO market is experiencing significant growth, with Tianfulong Group's successful listing reflecting the province's industrial upgrade and entrepreneurial spirit [4][19]. Company Overview - Tianfulong Group, founded by a couple from Jiangsu, has transitioned from a small chemical fiber factory to a publicly listed company with a market value of 280 billion yuan after its IPO at 23.6 yuan per share, which saw a 200% increase on the first day [3][5]. - The company operates five distinct production entities, focusing on differentiated polyester short fibers and has established production bases in Jiangsu, Guangdong, and Shanghai [10][14]. Financial Performance - Tianfulong's revenue is projected to grow from 2.576 billion yuan in 2022 to 3.841 billion yuan in 2024, with net profits increasing from 358 million yuan to 453 million yuan over the same period [14][15]. - The company heavily relies on tax incentives, which accounted for approximately 29.34% to 34.23% of its total profits from 2022 to 2024 [16]. Industry Context - Jiangsu has surpassed 700 listed companies, indicating a robust IPO environment and a thriving new materials industry, which has historical significance dating back to the late 1970s [4][17]. - The new materials industry cluster in Yangzhou has seen significant growth, with sales reaching 1,003 billion yuan in the first half of 2024, marking it as a key economic driver for the region [17]. Future Outlook - The Jiangsu province is actively developing strategic emerging industries, with a focus on creating competitive clusters and supporting innovation through funds and policies [20][21].